Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?

被引：17

作者：

Chatterjee, Srijan ^{[1
]}

Bhattacharya, Manojit ^{[2
]}

Dhama, Kuldeep ^{[3
]}

Lee, Sang-Soo ^{[1
]}

Chakraborty, Chiranjib ^{[4
]}

机构：

[1] Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthopaed Surg, Chuncheon Si 24252, Gangwon Do, South Korea

[2] Fakir Mohan Univ, Dept Zool, Balasore 756020, Odisha, India

[3] Indian Vet Res Inst, Div Pathol, ICAR, Bareilly 243122, Uttar Pradesh, India

[4] Adamas Univ, Sch Life Sci & Biotechnol, Dept Biotechnol, Kolkata 700126, W Bengal, India

来源：

MOLECULAR THERAPY-NUCLEIC ACIDS | 2023年 / 32卷

关键词：

RECEPTOR-BINDING DOMAIN; PROTEASE; DRUG;

D O I：

10.1016/j.omtn.2023.03.013

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：263 / 266

页数：4